Lakeway, NY -- (SBWIRE) -- 03/22/2013 -- ThePennyStockProfiler.com, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on the following stocks:-
Excel Maritime Carriers Ltd (NYSE:EXM) surged up 27.66% and closed at $0.90 on a traded volume of 4.43 million shares. Zacks restated neutral rating on Excel Maritime Carriers Ltd in a research note issued on Thursday. The firm currently has a $0.75 price target on the stock.
Is EXM a Still a Buy after the Solid momentum? Let’s Find out Here
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) jumped up 23.91% and closed at $8.24 on a traded volume of 22.32 million shares. The Company said that Jeffrey Cummings, M.D., Sc.D., Director of Cleveland Clinic Lou Ruvo Center for Brain Health, presented detailed results from ACADIA's pivotal Phase III -020 Study with pimavanserin in patients with Parkinson's disease psychosis at the Emerging Science session of the 65th American Academy of Neurology Annual Meeting. The analysis of the full data set from the Phase III -020 Study showed robust and consistent efficacy of pimavanserin across a wide array of study measures and confirmed the positive top-line results previously reported.
Is ACAD a Strong Buying Opportunity After The Recent Slump? Find out Here
Affymax, Inc. (NASDAQ:AFFY) went up 17.46% and closed at $1.48 on a traded volume of 20.78 million shares. Recently, the Company announced that it will reduce its total workforce by approximately 75%. The Company took this decision after it recalled all lots of Omontys voluntarily along with its partner Takeda Pharmaceutical Company Limited in Feb 2013. Affymax, Inc. is a biopharmaceutical company, engages in the development of drugs for the treatment of serious and life-threatening conditions in the United States.
Should AFFY Buy AFFY After The Recent Movement? Let’s Find out Here
Harvest Natural Resources, Inc. (NYSE:HNR) surged up 15.98% and closed at $3.92 on a traded volume of 2.0 million shares. Lifshitz Law Firm announces that it is investigating potential claims against the board of directors of Harvest Natural Resources, Inc. concerning whether the board has breached its fiduciary duties to shareholders. On March 19, 2013, the Company disclosed that certain errors were identified that will require the Company to revise and possibly restate its financial statements for certain periods in 2010, 2011 and 2012.
Is HNR a Strong Buying Opportunity After The Recent Slump? Find out Here
ThePennyStockProfiler.com is engaged in providing the most up to date and useful information on Microcap Stocks poised to breakout. ThePennyStockProfiler.com also provides investors with trend analysis, detailed company profiles, and most importantly a much needed "informational edge" which can be used as a tool for making investment decisions. To Receive Instant updates in the inbox, readers are advised to sign up for free at http://www.ThePennyStockProfiler.com
The assembled information disseminated by ThePennyStockProfiler.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. ThePennyStockProfiler.com does expect that investors will buy and sell securities based on information assembled and presented in phd-trading.com. PLEASE always do your own due diligence, and consult your financial advisor.
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-321-1250 (International)